Advancing therapeutic interventions for NUT carcinoma: Orchestrating the precision of CRISPR/Cas9-mediated NUTM1 suppression and synergistic ADC strategies

被引：0
|
作者：
Choi, Juyoung
Yi, Hwa Lin
Park, Hee Geon
Lee, Misook
Kim, Daesik
Hong, Sung Youl
Shin, Young Kee
Choi, Yoon-la
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1910
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1910
引用
收藏
页数：2
相关论文
共 21 条
  • [1] CRISPR/Cas9-mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell line
    Prattapong, Pongphol
    Ngernsombat, Chawalit
    Aimjongjun, Sathid
    Janvilisri, Tavan
    CANCER REPORTS, 2020, 3 (02)
  • [2] CRISPR/Cas9-mediated hypoxia inducible factor-1α knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinoma
    Liu, Quan
    Fan, Dahua
    Adah, Dickson
    Wu, Zhengzhi
    Liu, Renyan
    Yan, Qiao-Ting
    Zhang, Yue
    Du, Zhi-Yong
    Wang, Dou
    Li, Yan
    Bao, Shi-Yun
    Liu, Li-Ping
    ONCOLOGY REPORTS, 2018, 40 (05) : 2547 - 2557
  • [3] Efficient CRISPR/Cas9-Mediated Knockout of an EndogenousPHYTOENE DESATURASEGene in T1 Progeny of ApomicticHieraciumEnables New Strategies for Apomixis Gene Identification
    Henderson, Sam W.
    Henderson, Steven T.
    Goetz, Marc
    Koltunow, Anna M. G.
    GENES, 2020, 11 (09) : 1 - 16
  • [4] CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth
    Haifeng Huo
    Guohua Hu
    Infectious Agents and Cancer, 14
  • [5] CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth
    Huo, Haifeng
    Hu, Guohua
    INFECTIOUS AGENTS AND CANCER, 2019, 14 (01)
  • [6] CRISPR/Cas9-Mediated CtBP1 Gene Editing Enhances Chemosensitivity and Inhibits Metastatic Potential in Esophageal Squamous Cell Carcinoma Cells
    Akhtar, Javed
    Imran, Muhammad
    Wang, Guanyu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [7] CRISPR/CAS9-MEDIATED MIR-210-3P DEPLETION PROMOTED TUMORIGENESIS THROUGH REVIVAL OF TWIST1 IN RENAL CELL CARCINOMA
    Yoshino, Hirofumi
    Yonemori, Masaya
    Miyamoto, Kazutaka
    Kofuji, Satoshi
    Nohata, Nijiro
    Enokida, Hideki
    Nakagawa, Masayuki
    JOURNAL OF UROLOGY, 2017, 197 (04): : E796 - E796
  • [8] CRISPR/Cas9-mediated knockout of DYRK1B in triple-negative breast cancer cells: implications for cell proliferation, apoptosis, and therapeutic sensitivity
    Rashidi, Asrin
    Fuchtbauer, Ernst-Martin
    Vahabzadeh, Zakaria
    Soleimani, Farzad
    Rahimi, Karim
    Nikkhoo, Bahram
    Fakhari, Shohreh
    Erfan, Mohammad Bagher Khadem
    Azarnezhad, Asaad
    Pooladi, Arash
    Soheili, Fariborz
    Fathi, Fardin
    BIOCHEMICAL ENGINEERING JOURNAL, 2025, 213
  • [9] ROR-1 CAR-T cells with CRISPR/Cas9-mediated glucocorticoid receptor knockout exert potent antitumor efficacy in advanced adrenocortical carcinoma
    Schauer, M. P.
    Altieri, B.
    Redondo-Frutos, R.
    Spieler, P.
    Maier, T.
    Oppelt, D.
    Kroiss, M.
    Sbiera, S.
    Weber, J.
    Landwehr, L. -S.
    Fassnacht, M.
    Hudecek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 143 - 144
  • [10] Targeting E2F1-downstream pathways in invasive bladder cancer for therapeutic intervention by combining CRISPR/Cas9-mediated genome editing and adenoviral vectors
    Jansen, B. A.
    Solanki, M.
    Spitschak, A.
    Rieger, C.
    Erbersdobler, A.
    Taher, L.
    Heckl, D.
    Herchenroeder, O.
    Fuessel, S.
    Puetzer, B. M.
    HUMAN GENE THERAPY, 2017, 28 (12) : A24 - A24
123